Mosaic Family Wealth’s Aratana Therapeutics, Inc. PETX Stock Holding History

Mosaic Family Wealth’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$4K	–	689
2019 Q1	$4K	Hold	1,000	–	–	﹤0.01%	606
2018 Q4	$6K	Hold	1,000	–	–	﹤0.01%	544
2018 Q3	$6K	Hold	1,000	–	–	﹤0.01%	550
2018 Q2	$4K	Hold	1,000	–	–	﹤0.01%	613
2018 Q1	$4K	Hold	1,000	–	–	﹤0.01%	607
2017 Q4	$5K	Hold	1,000	–	–	﹤0.01%	600
2017 Q3	$6K	Hold	1,000	–	–	﹤0.01%	683
2017 Q2	$7K	Hold	1,000	–	–	﹤0.01%	540
2017 Q1	$5K	Hold	1,000	–	–	﹤0.01%	596
2016 Q4	$7K	Hold	1,000	–	–	﹤0.01%	524
2016 Q3	$9K	Hold	1,000	–	–	﹤0.01%	526
2016 Q2	$7K	Buy	+1,000	New	+$6.43K	﹤0.01%	573

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Mosaic Family Wealth's PETX Position: Q2 2019 in Review

Mosaic Family Wealth sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 1,000 shares — an estimated $4K sold.

Mosaic Family Wealth first reported a position in PETX in Q2 2016 and held it in 12 quarters. The position peaked at $9K in Q3 2016. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

Mosaic Family Wealth reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Mosaic Family Wealth sold 1,000 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $4K.
Mosaic Family Wealth first reported a position in Aratana Therapeutics, Inc. in Q2 2016 and held it in 12 quarters.
Mosaic Family Wealth's Aratana Therapeutics, Inc. position peaked at $9K in Q3 2016.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Mosaic Family Wealth's 13F filing for Q2 2019, filed 12 Aug 2019.